Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Translate Bio Crashed 21% Today

TheMotleyFool

0 0

After the company announced the pricing of a planned $125 million secondary stock offering, shares of Translate Bio (NASDAQ: TBIO) tumbled 21% on Friday.

In collaboration with biopharma giant Sanofi (NASDAQ: SNY), Translate Bio has been investigating mRNA vaccine candidates for COVID-19 since March. On Tuesday, the companies announced they're expanding their relationship, with Translate Bio receiving upfront money, potential milestone payments, and royalties on future net sales in exchange for exclusive commercial rights to multiple vaccine candidates.

IMAGE SOURCE: GETTY IMAGES.

Source Fool.com

Like: 0

TBIO

Teilen